Immediate Impact
56 standout
Citing Papers
Targeting ROS in cancer: rationale and strategies
2024 Standout
FGFR-targeted therapeutics: clinical activity, mechanisms of resistance and new directions
2024 Standout
Works of Go Masuda being referenced
Clinical difference between fibroblast growth factor receptor 2 subclass, type IIIb and type IIIc, in gastric cancer
2021
Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer
2014
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Go Masuda | 211 | 346 | 185 | 34 | 614 | |
| Haruhito Kinoshita | 205 | 278 | 145 | 30 | 513 | |
| Xinhai Zhang | 206 | 330 | 134 | 25 | 661 | |
| Zhenfeng Guan | 182 | 352 | 167 | 23 | 628 | |
| Qing Yang | 189 | 410 | 187 | 29 | 724 | |
| Wenhao Luo | 308 | 308 | 254 | 44 | 722 | |
| Seok‐Hyun Kim | 257 | 387 | 118 | 39 | 724 | |
| Zuo‐Lin Xiang | 222 | 277 | 235 | 36 | 607 | |
| Mengxuan Yang | 226 | 268 | 150 | 26 | 561 | |
| Dianyun Ren | 250 | 394 | 194 | 25 | 660 | |
| Chengyong Dong | 199 | 376 | 240 | 28 | 696 |
All Works
Loading papers...